Operating Company Healthcare

LUX Infusion

Plantation, Florida, United States

Formerly known as BioMatrix Infusion, BioMatrix Infusion Pharmacy, BioMatrix Specialty Pharmacy

LUX Infusion is a U.S.-based, clinician-led infusion services company providing home infusion and ambulatory infusion center services, with faster therapy starts and dedicated patient support while sharing continuous data with providers to support adherence and outcomes.

Focus Areas
Home Infusion Services, Ambulatory Infusion Center, Specialty Pharmacy
Website
luxinfusion.com

Tracked deals

5

5 tracked deals across 2020-2025.

Recent pace

3

3 tracked deals announced in the last 12 months.

Deal mix

Buyout

5 buyout

LUX Infusion Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for LUX Infusion. 1 2020 1 2021 3 2025

Supporting Data

Recent Transactions

  • Buyer
    BioMatrix Infusion Pharmacy
    Target
    First Choice Wellness Centers, LLC
    Seller
    Mark Osborne (Owner, First Choice Wellness Centers)
    Type
    Buyout

    BioMatrix Infusion Pharmacy acquired First Choice Wellness Centers, LLC (transaction closed December 10, 2025) to expand its ambulatory and home infusion footprint across the Southeast. First Choice operates eleven ambulatory infusion centers across Alabama, Florida, Georgia, Kentucky and Tennessee, bringing referral relationships, patient volume and payer access that support BioMatrix's community-based infusion strategy.

  • Buyer
    BioMatrix Infusion Pharmacy
    Target
    Total Infusion Care
    Type
    Buyout

    BioMatrix Infusion Pharmacy acquired Total Infusion Care (TIC), a Nevada-based provider of home and ambulatory infusion therapy serving patients across the western United States. The transaction closed on November 7, 2025, and TIC’s Henderson, Nevada location will continue operating as part of the BioMatrix network.

  • Buyer
    BioMatrix Infusion Pharmacy
    Target
    LUX Infusion
    Type
    Buyout

    BioMatrix Infusion Pharmacy acquired LUX Infusion, an Alaska-based ambulatory infusion center operator, adding three infusion centers effective October 17, 2025. The deal expands BioMatrix's national ambulatory infusion footprint and integrates LUX's clinical teams and operating model to accelerate growth and extend home infusion nursing into the Pacific Northwest.

  • Buyer
    BioMatrix Specialty Pharmacy
    Target
    InfuCare LTD
    Seller
    InfuCare LTD (owners/partners), Gary Wyatt (Partner, InfuCare)
    Type
    Buyout

    BioMatrix Specialty Pharmacy, based in Plantation, Florida, has acquired InfuCare LTD, a home infusion specialty pharmacy in Tyler, Texas. The transaction adds a Texas brick-and-mortar location to BioMatrix's national footprint and expands its infusion capabilities, payer contracts, and access to covered lives for therapies such as IVIG, anti-infectives, and parenteral nutrition.

  • Buyer
    BioMatrix Specialty Pharmacy
    Target
    City Drugs Specialty Pharmacy
    Type
    Buyout

    BioMatrix Specialty Pharmacy has acquired City Drugs Specialty Pharmacy, a specialty pharmacy located on the Upper East Side of Manhattan. The deal expands BioMatrix's national footprint to 12 pharmacy locations and adds payer contracts, clinical staff experienced in rare and chronic conditions, and capabilities across oncology, hepatitis, autoimmune and gastroenterology therapeutic areas.

Related Acquisition Pages

Selling a company? Get in front of buyers like LUX Infusion

Turn tracked acquisition activity into an outreach-ready buyer list.